Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ban Xia Xie Xin Decoction and Bismuth Quadruple Therapy for H. Pylori Eradication
NCT05586464Phase 1Unknown
- Sponsor
- Liaocheng City People's Hospital
- Start
- Nov 2022
- Primary completion
- Sep 2024
- Modality
- Herbal Formulation
01
Overview
Phase 1, randomised, open-label trial of Banxia Xiexin Decoction in Helicobacter pylori infection (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: The helicobacter pylori clearance rate at 45 days. Status: unknown.
02
Drugs
Banxia Xiexin Decoction
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05586464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586464.